CJC-1295 (NO DAC) – 5mg
$50.00
CJC-1295 (No DAC)
CJC-1295 (No DAC) is a synthetic peptide that promotes the release of growth hormone by stimulating the pituitary gland. Unlike its DAC counterpart, this version lacks the Drug Affinity Complex, which means it has a shorter half-life and is typically administered more frequently. CJC-1295 (No DAC) is of interest in research for its effects on muscle growth, fat metabolism, and general tissue regeneration through the stimulation of growth hormone.
Potential Research Applications
CJC-1295 (No DAC) is currently being explored in research settings for its role in:
- Growth Hormone Stimulation: Investigated for its potential to increase growth hormone levels, contributing to muscle growth and tissue repair.
- Muscle & Fat Metabolism: Studied for its role in promoting lean muscle mass and fat loss.
- Regeneration & Anti-Aging: Researched for its potential benefits in cellular regeneration and overall metabolic health.
✔ High-Quality Research Peptide – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates growth hormone (GH) secretion. Unlike the DAC-modified version, this form has a much shorter half-life, leading to a more natural pulsatile release of GH. Researchers have studied its ability to increase GH and insulin-like growth factor 1 (IGF-1) levels. These factors are essential for protein synthesis, metabolic regulation, and cellular repair.
Studies explore the effects of CJC-1295 without DAC on GH pulsatility. Maintaining the body’s natural secretion pattern is crucial for physiological balance. This peptide has shown potential in promoting lipolysis, breaking down stored fat, and influencing lean tissue composition. Unlike the DAC-modified version, the non-DAC form produces shorter-duration GH spikes, better matching the body's natural release patterns.
Research also investigates its interactions with other growth hormone secretagogues. Scientists aim to optimize GH release dynamics. They study its applications in cellular regeneration, tissue integrity, and metabolic efficiency. However, its shorter half-life requires more frequent administration in experiments.
The pharmacokinetic differences between CJC-1295 with and without DAC remain a key research focus. The DAC-modified version extends GH elevation, while CJC-1295 without DAC triggers a transient yet physiologically relevant GH release. Further studies are needed to fully understand its potential in endocrine and metabolic research.
For Research Use Only
No Certificate of Analysis images available for this product.
